Biologic concentration testing in inflammatory bowel disease

Keyphrases

• Inflammatory Bowel Disease 100%
• Anti-tumor Necrosis Factor (anti-TNF) 100%
• Pharmacokinetics 20%
• Immune Response 20%
• Pharmacodynamics 20%
• Immunogenicity 20%
• Clinical Practice 20%
• Patient Care 20%
• Disease Symptoms 20%
• Titration 20%
• Clinical Benefit 20%
• Dose Optimization 20%
• Drug Concentration 20%
• Therapeutic Concentrations 20%
• Loss of Response 20%
• Rescue Therapy 20%
• Therapeutic Window 20%
• Concentration Monitoring 20%
• Plasma Drug Concentration 20%
• Proactive Monitoring 20%
• Drug Antibodies 20%
• Clinical Outcomes 20%

Medicine and Dentistry

• Tumor Necrosis Factor 100%
• Inflammatory Bowel Disease 100%
• Symptom 20%
• Drug Therapy 20%
• Patient with Inflammatory Bowel Disease 20%
• Pharmacokinetics 20%
• Pharmacodynamics 20%
• Rescue Therapy 20%
• Titrimetry 20%
• Immunogenicity 20%
• Therapeutic Window 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• Tumor Necrosis Factor 100%
• Drug Concentration 40%
• Pharmacodynamics 20%
• Immunogenicity 20%
• Pharmacokinetics 20%
• Symptom 20%
• Therapeutic Window 20%